• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Cancers >Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey
【2h】

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey

机译：按筛查项目类型在欧洲国家中对大肠癌筛查测试的利用：欧洲健康访谈调查的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In the past two decades, an extensive rollout of colorectal cancer (CRC) screening programmes has been initiated in European countries with a large heterogeneity of screening offers. Using data from a population-based cross-sectional survey conducted between 2013 and 2016 in all European Union countries, we analysed the utilisation of faecal tests and colonoscopy among people aged 50–74 years and the factors associated with uptake by type of screening offer. We observed the highest utilisation of either test for countries with fully rolled out organised programmes with faecal tests (ranging from 29.7% in Croatia to 66.7% in the UK) and countries offering both faecal tests and colonoscopy (from 22.7% in Greece to 70.9% in Germany). Utilisation was very low for countries with no programme (from 6.3% in Romania to 30.5% in Norway). Younger age (50–54 years), longer time since last consultation with a doctor and a lifestyle score associated with increased CRC risk were significantly associated with lower test use, a pattern observed across all types of screening offers. Our results suggest that more countries should implement organised programmes with faecal immunochemical tests, in combination with alternative endoscopy offers where resources allow. Furthermore, there is a large potential for increasing screening use in Europe by better reaching the younger eligible individuals, those who have not been to the doctor recently and those at increased risk for CRC.
机译：在过去的二十年中，在欧洲各国开展了大范围的结肠直肠癌（CRC）筛查项目，这些筛查项目具有很大的异质性。我们使用2013年至2016年间在所有欧盟国家进行的基于人口的横断面调查的数据，我们分析了50-74岁人群中粪便检查和结肠镜检查的使用情况以及按筛查提议类型进行摄取的相关因素。对于采用粪便检测的组织计划全面展开的国家（从​​克罗地亚的29.7％到英国的66.7％）以及同时提供粪便检测和结肠镜检查的国家（从​​希腊的22.7％到70.9％），我们观察到两种检测的利用率最高在德国）。对于没有计划的国家，利用率非常低（从罗马尼亚的6.3％到挪威的30.5％）。年龄较小（50-54岁），自上次咨询医生以来的时间较长以及与CRC风险增加相关的生活方式得分与较低的测试使用率显着相关，在所有类型的筛查活动中均观察到这种模式。我们的结果表明，更多国家应在资源允许的情况下，结合粪便内窥镜检查技术，实施粪便免疫化学测试的有组织计划。此外，在欧洲，通过更好地接触年轻的合格个体，最近没有去过医生的人和罹患CRC风险增加的人，在筛查中的应用潜力很大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号